Osteoinduction in the palatal submucosa by injecting BMP-2 on 2 different carriers

Journal of Craniofacial Surgery

Volumn 23, Issue 2, 2012, Pages 594-598

  Martínez Sanz, Elena ^a,b   Alkhraisat, Mohammad H ^c   Paradas, Irene ^b   López, Yamila ^b   Maldonado, Estela ^b   González Meli, Beatriz ^d   Berenguer, Beatriz ^d   López Cabarcos, Enrique ^c   Martínez, Ma Luisa ^e   Martínez Álvarez, Concepción ^b  

^a Unidad Calidad   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

brushite cement; cleft palate; collagen gel; Injectable carriers; rhBMP 2

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE DIBASIC; COLLAGEN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BONE DEVELOPMENT; CLEFT PALATE; COSMODERM; DRUG EFFECT; ENZYME IMMUNOASSAY; HARD PALATE; HUMAN; INJECTION; PROSTHESES AND ORTHOSES; RAT; WISTAR RAT;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATES; CLEFT PALATE; COLLAGEN; HUMANS; IMMUNOENZYME TECHNIQUES; INJECTIONS; OSTEOGENESIS; PALATE, HARD; PROSTHESES AND IMPLANTS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84859178961     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e31824cd6c7     Document Type: Article

References (35)

1. Sadove AM, van Aalst JA, Culp JA. Cleft palate repair: art and issues. Clin Plast Surg 2004;31:231-241 (Pubitemid 38638153)
2. Resel E, Martínez-Sanz E, González I, et al. In vitro manipulation of cleft palate connective tissue. Setting the bases of a proposed new treatment. J Surg Res 2007;138:111-120 (Pubitemid 46237635)
3. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988;242: 1528-1534 (Pubitemid 19023695)
4. Harris SE, Bonewald LF, Harris MA, et al. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 1994;9: 855-863
5. Okubo Y, Bessho K, Fujimura K, et al. Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites. Int J Oral Maxillofac Surg 2000;29:62-66
6. Kim CS, Kim JI, Kim J, et al. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. Biomaterials 2005;26:2501-2507 (Pubitemid 39600702)
7. Liang G, Yang Y, Oh S, et al. Ectopic osteoinduction and early degradation of recombinant human bone morphogenetic protein-2Yloaded porous beta-tricalcium phosphate in mice. Biomaterials 2005;26:4265-4271 (Pubitemid 40430854)
8. Na K, Kim SW, Sun BK, et al. Osteogenic differentiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morphogenic protein-2 (BMP-2). Biomaterials 2007;28:2631-2637 (Pubitemid 46389528)
9. Urist MR. Bone: formation by autoinduction. Science 1965;150: 893-899
10. De Biase P, Capanna R. Clinical applications of BMPs. Injury 2005;36(suppl 3):S43YS46
11. Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2008;2:1-13
12. Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2008;2:81-96
13. Fujimura K, Bessho K, Kusumoto K, et al. Experimental studies on bone inducing activity of composites of atelopeptide type I collagen as a carrier for ectopic osteoinduction by rhBMP-2. Biochem Biophys Res Commun 1995;208:316-322
14. Urist MR, Lietze A, Dawson E. beta-Tricalcium phosphate delivery system for bone morphogenetic protein. Clin Orthop Relat Res 1984;187:277-280 (Pubitemid 14063258)
15. Steffen T, Marchesi D, Aebi M. Posterolateral and anterior interbody spinal fusion models in the sheep. Clin Orthop Relat Res 2000;371:28-37 (Pubitemid 30090818)
16. Jingushi S, Urabe K, Okazaki K, et al. Intramuscular bone induction by human recombinant bone morphogenetic protein-2 with beta-tricalcium phosphate as a carrier: in vivo bone banking for muscle-pedicle autograft. J Orthop Sci 2002;7:490-494 (Pubitemid 34947844)
17. Kaito T, Myoui A, Takaoka K, et al. Potentiation of the activity of bone morphogenetic protein-2 in bone regeneration by a PLA-PEG/hydroxyapatite composite. Biomaterials 2005;26:73-79 (Pubitemid 38759473)
18. Saito N, Okada T, Horiuchi H, et al. Local bone formation by injection of recombinant human bone morphogenetic protein-2 contained in polymer carriers. Bone 2003;32:381-386 (Pubitemid 36407538)
19. Hou LT, Liu CM, Liu BY, et al. Tissue engineering bone formation in novel recombinant human bone morphogenic protein 2-atelocollagen composite scaffolds. J Periodontol 2007;78:335-343
20. Bessho K, Carnes DL, Cavin R, et al. Experimental studies on bone induction using low-molecular-weight poly (DL-lactide-co-glycolide) as a carrier for recombinant human bone morphogenetic protein-2. J Biomed Mater Res 2002;61:61-65 (Pubitemid 34650257)
21. Keskin DS, Tezcaner A, Korkusuz P, et al. Collagen-chondroitin sulfate-based PLLA-SAIBYcoated rhBMP-2 delivery system for bone repair. Biomaterials 2005;26:4023-4034 (Pubitemid 40038791)
22. Schliephake H. Application of bone growth factorsVthe potential of different carrier systems. Oral Maxillofac Surg 2010;14:17-22
23. Martínez-Sanz E, Casado-Gómez I, Martín C, et al. A new technique for feeding dogs with a congenital cleft palate for surgical research. Lab Anim 2011;45:70-80
24. Tamimi F, Torres J, Lopez-Cabarcos E, et al. Minimally invasive maxillofacial vertical bone augmentation using brushite based cements. Biomaterials 2009;30:208-216
25. Boyne PJ. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects. J Bone Joint Surg Am 2001;83-A suppl 1(Pt 2):S146YS150
26. Owen TA, Aronow M, Shalhoub V, et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990;143:420-430
27. Zohar R, Cheifetz S, McCulloch CA, et al. Analysis of intracellular osteopontin as a marker of osteoblastic cell differentiation and mesenchymal cell migration. Eur J Oral Sci 1998;106(suppl 1): 401-407 (Pubitemid 128737256)
28. Chen D, Harris MA, Rossini G, et al. Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts. Calcif Tissue Int 1997;60:283-290 (Pubitemid 27106254)
29. Hyun SJ, Han DK, Choi SH, et al. Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects. J Periodontol 2005;76:1667-1674
30. Kato M, Toyoda H, Namikawa T, et al. Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2). Biomaterials 2006;27:2035-2041 (Pubitemid 41759497)
31. Kato M, Namikawa T, Terai H, et al. Ectopic bone formation in mice associated with a lactic acid/dioxanone/ethylene glycol copolymer-tricalcium phosphate composite with added recombinant human bone morphogenetic protein-2. Biomaterials 2006;27: 3927-3933
32. Barboza EP, Caúla AL, Caúla FO, et al. Effect of recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge with space-providing biomaterials on the augmentation of chronic alveolar ridge defects. J Periodontol 2004;75:702-708
33. Hunt DR, Jovanovic SA, WikesjöUM, et al. Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A pilot study. J Periodontol 2001;72:651-658 (Pubitemid 32479934)
34. Howell TH, Fiorellini J, Jones A, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 1997;17:124-139
35. Martínez-Sanz E, Ossipov DA, Hilborn J, et al. Bone reservoir: injectable hyaluronic acid hydrogel for minimal invasive bone augmentation. J Control Release 2011;152:232-240